Dr. Cindy Jayee Kin, MD

Dr. Kin practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Kin's NPI, 1972790178, was assigned on October 2, 2007. Dr. Kin graduated from Vagelos College of Physicians and Surgeons in 2006. Dr. Kin holds California license 0.

Dr. Kin's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Kin's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Kin to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Kin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kin practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Kin's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Kin is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Kin's licenses on file in 2 states: California and Ohio.

Dmand AI lists colonoscopy, colon removal, gastrointestinal obstruction and hemorrhoids among the conditions Dr. Kin treats.

CMS data shows 104 Medicare services from Dr. Kin across 4 procedure codes in 2024, for 115 Medicare patients. Medicare paid $10,798 for them.

CMS counts 115 Medicare patients who saw Dr. Kin in 2024. The largest group is 65 to 74, with 58 patients. 73% of them have high blood pressure, and 67% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kin's median patient age at 57, with 52% women.

In 2024, Dr. Kin wrote 79 Medicare Part D claims for 33 patients. 89% of them were for generic drugs. CMS names the drug for 52 of them, across 3 drugs with 11 or more claims each, at $327 in total drug cost. In 2023, CMS named 54 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Kin for performance year 2024, reported as part of a group. Dr. Kin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kin as offering telehealth. CMS counts 17 procedures of colonoscopy by Dr. Kin, more than 46% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 84 papers to Dr. Kin, published from 2012 to 2025. 2017 was the busiest year, with 7. The most frequent topics are Postoperative Complications, Preoperative Exercise and Colectomy. Dr. Kin has published most often in Dis Colon Rectum. Dr. Kin's most frequent co-authors are Andrew Alan Shelton, MD, Arden Marie Morris, MD and Lindsay Anne Sceats, MD.

Dmand AI links Dr. Kin to 6 clinical trials. 3 are still active or recruiting. Conditions studied include Motor Activity, Rectal Diseases and Frailty. Stanford University sponsors the most, 6.

CMS Open Payments shows 18 general payments to Dr. Kin from 3 drug and device companies from 2016 to 2024. Education make up the largest share, 81% of the total. Intuitive Surgical, Inc. paid the most, $9,712.

Dr. Kin graduated from Vagelos College of Physicians and Surgeons in 2006. Dr. Kin is a member of American College of Lifestyle Medicine, ACS, ASCRS, AAS and Pacific Coast Surgical Association.

Dr. Kin is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.